https://doi.org/10.4081/jbr.2014.2135

K:D-Rib: cancer cell proliferation inibitor and DNAzyme folding promoter

Vol. 87 No. 1 (2014): Proceedings of the 85th SIBS Congress
Submitted: November 21, 2013
Accepted: November 21, 2013
Published: January 10, 2014
HTB-126 cell line, DNAzyme, cancer, K ion and D-ribose
Abstract Views: 1351
PDF: 1202
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Luca Bruni
luca.bruni@nemo.unipr.it
Unit of Biophysics and Medical Physics, Department of Neuroscience, University of Parma, Italy.
Simonetta Croci
INBB National Institute of Biostructures and Biosystems, Rome, Italy.
We report the effects of K:D-Rib, a D-ribose and KHCO3 water solution on HTB-126 human cancer cell line proliferation and the preliminary ultraviolet-visible (UV-VIS) measures of DNAzyme as biosensor of extracellular K+ concentration. On the one hand, we demonstrate that the synergic action of KHCO3 and D-ribose from one side has a cytostatic effect on human breast cancer cell line increasing by 30% the doubling population time of treated cells with respect to the control; and on the other hand we demonstrate how it seems to permit the K+ uptake.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

this investigation was supported by the Valsè Pantellini Foundation, Oviedo, Spain, and Fondazione Cariparma, Parma, Italy

How to Cite

Bruni, L., & Croci, S. (2014). K:D-Rib: cancer cell proliferation inibitor and DNAzyme folding promoter. Journal of Biological Research - Bollettino Della Società Italiana Di Biologia Sperimentale, 87(1). https://doi.org/10.4081/jbr.2014.2135

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.